Travere Therapeutics (TVTX) SEC Filings & 10K Form

$5.28
-0.11 (-2.04%)
(As of 02:27 PM ET)

Recent Travere Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2024
3:05 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:35 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form ARS
03/27/2024
3:31 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEF 14A
03/27/2024
3:31 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEF 14A
03/27/2024
3:33 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEFA14A
02/20/2024
7:10 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:35 PM
ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/14/2024
5:38 AM
MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/09/2024
9:33 AM
MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
02/07/2024
6:37 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/01/2024
8:57 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
11:44 AM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
10:39 AM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:52 AM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/25/2024
8:24 AM
STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
01/23/2024
12:17 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:51 AM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:52 AM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:07 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:11 PM
Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
4:14 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
09/21/2023
6:35 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
6:35 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
4:00 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K/A
09/05/2023
7:10 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
7:12 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
7:13 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
7:15 PM
Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
11:54 AM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
11:43 AM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
11:34 AM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
7:35 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
7:07 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
12:39 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
11:58 AM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
3:46 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TVTX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners